NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...
It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes painful scalp conditions like seborrheic dermatitis, that can be easier said ...
Chronic hand eczema affects emotional health, daily activities, and relationships, leading to social isolation and discrimination. The condition imposes financial burdens, impacting work performance ...
(Mass Appeal)—Hand dermatitis, or eczema, is common. It’s caused by a combination of hereditary and environmental factors, and the cold weather we’ve been having certainly doesn’t help. Dr. Stanley ...
Definition. Approximately 80% of all HD cases involve irritant contact dermatitis (ICD). Contact dermatitis of the hands can be either irritant or allergic in etiology (Goh, 1989). Irritants are ...
The MarketWatch News Department was not involved in the creation of this content. -- ADHAND is a phase 3b placebo-controlled clinical trial evaluating the efficacy and safety of tralokinumab in adult ...
LEO Pharma has reported positive outcomes from the 16-week interim analysis of the randomised Phase IIIb ADHAND trial of fully human biologic, tralokinumab, to treat adults with moderate-to-severe ...
Patient-reported data reveal substantial gaps between clinical perception and lived experience across sleep, mental health, and daily functioningEXTON, PA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- More than ...
Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback